Donghan (Don) Luo, PhD, Associate Director, Biostatistics, Janssen Research and Development, USA* Interviewed by Eric Y. Wong, PhD, MBA, ISMPP CMPP™, Janssen Scientific Affairs, LLC, and with contributions from Robert Matheis, PhD, MA, ISMPP CMPP™, Celgene...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
The Center for Biomedical Research Transparency (CBMRT) was established in 2017 with a mission to increase transparency in biomedical research reporting. CBMRT aims to ensure that all high-quality biomedical research results – including negative and inconclusive...
Simon Fry, Springer Healthcare Artificial intelligence (AI) is being researched and applied in many industries, and it is showing promise in the clinic. Given this trend, what might be the effect of AI on the medical communications landscape and its expert...
ISMPP is pleased to share information about publications on ghostwriting, authorship practices for medical writers, and publication ethics; an article on patient centricity; an extension of the CONSORT 2010 Statement for reporting multi-arm trials; and the 49 posters...
ISMPP Insider is an informational and educational service intended for ISMPP members and the broader medical communications community. It is not meant as a basis for individual companies to make policy and/or procedural decisions, which should be made in consultation with the company’s Legal and/or Compliance representatives. The articles in ISMPP Insider do not necessarily represent the views of ISMPP.
ISMPP will grant limited permission to use postings and articles in ISMPP Insider for personal and noncommercial use. Permission requests or questions should be directed to ISMPP (ismpp@ismpp.org).
